Day 1 of the annual European Committee for Treatment and Research in Multiple Sclerosis

Resource
Written By Lauren Anderson

Day 1 of the annual European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, this year being held in Stockholm, Sweden, has now concluded. At the end of the day, our co-founder and chief science communicator, Brett Drummond, sat down with MStranslate guest reporter, Dr Travis Stiles (CEO, Novoron Bioscience), to discuss the key research and treatment themes explored throughout the day. Topics covered include HSCT, remyelination, imaging and the role of environmental factors.

Learn more about the ECTRIMS Congress here: ectrims-congress.eu/2019

Lauren Anderson

Founder | CEO

Previous

Day 2 of the European Committee for Treatment and Research of Multiple Sclerosis Congress

Next

Novoron Bioscience - Reversing Central Nervous System Disorders + Diseases (feat. Travis Stiles)